Trial · NCT00538785
Adverse events646
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 646
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | ANAEMIA | Blood and lymphatic system disorders | Motavizumab (MEDI-524) | 14 | 618 | 15 |
| other | ANAEMIA | Blood and lymphatic system disorders | Palivizumab | 16 | 612 | 22 |
| other | CARDIAC FAILURE | Cardiac disorders | Motavizumab (MEDI-524) | 9 | 618 | 10 |
| other | CARDIAC FAILURE | Cardiac disorders | Palivizumab | 10 | 612 | 10 |
| other | CYANOSIS | Cardiac disorders | Motavizumab (MEDI-524) | 25 | 618 | 42 |
| other | CYANOSIS | Cardiac disorders | Palivizumab | 25 | 612 | 32 |
| other | CONJUNCTIVITIS | Eye disorders | Motavizumab (MEDI-524) | 39 | 618 | 42 |
| other | CONJUNCTIVITIS | Eye disorders | Palivizumab | 27 | 612 | 32 |
| other | CONSTIPATION | Gastrointestinal disorders | Motavizumab (MEDI-524) | 44 | 618 | 47 |
| other | CONSTIPATION | Gastrointestinal disorders | Palivizumab | 31 | 612 | 35 |
| other | DIARRHOEA | Gastrointestinal disorders | Motavizumab (MEDI-524) | 69 | 618 | 80 |
| other | DIARRHOEA | Gastrointestinal disorders | Palivizumab | 64 | 612 | 70 |
| other | FLATULENCE | Gastrointestinal disorders | Motavizumab (MEDI-524) | 5 | 618 | 5 |
| other | FLATULENCE | Gastrointestinal disorders | Palivizumab | 6 | 612 | 7 |
| other | ENTERITIS | Gastrointestinal disorders | Motavizumab (MEDI-524) | 7 | 618 | 8 |
| other | ENTERITIS | Gastrointestinal disorders | Palivizumab | 4 | 612 | 4 |
| other | GASTROOESOPHAGEAL REFLUX DISEASE | Gastrointestinal disorders | Motavizumab (MEDI-524) | 19 | 618 | 19 |
| other | GASTROOESOPHAGEAL REFLUX DISEASE | Gastrointestinal disorders | Palivizumab | 23 | 612 | 23 |
| other | TEETHING | Gastrointestinal disorders | Motavizumab (MEDI-524) | 44 | 618 | 54 |
| other | TEETHING | Gastrointestinal disorders | Palivizumab | 36 | 612 | 56 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00538785/events